Merck & Co. Inc.

In News

Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case - The Wall Street Journal

The Wall Street Journal - Dec 04, 2025

Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? - The Motley Fool

The Motley Fool - Dec 07, 2025

Merck suffers a setback over its new Keytruda formulation in Germany - statnews.com

statnews.com - Dec 05, 2025

Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany - PR Newswire

PR Newswire - Dec 04, 2025

Merck's Keytruda SC launch in Germany faces new hurdle as Halozyme scores preliminary injunction - Fierce Pharma

Fierce Pharma - Dec 05, 2025

FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis) - BioSpace

BioSpace - Dec 05, 2025

Halozyme granted injunction in Germany barring Merck's subcutaneous Keytruda - Seeking Alpha

Seeking Alpha - Dec 04, 2025

Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent - Business Wire

Business Wire - Nov 14, 2025

New Pill From Merck Could Slash Cholesterol Levels, Trials Show - NY Times

NY Times - Nov 08, 2025

Merck Kicks Off US Dollar Bond Sale to Help Fund Cidara Deal - Bloomberg.com

Bloomberg.com - Dec 01, 2025

Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? - Yahoo Finance

Yahoo Finance - Dec 07, 2025

Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results - NeurologyLive

NeurologyLive - Dec 05, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment